Clever biomolecular labelling enables identification of immune cells
New strategy for labelling peptides
biomolecules regulate the biological functions inside every living cell. If scientists can understand the molecular mechanisms of such functions, then it is possible to detect severe dysfunction which can lead to illness. At a molecular level, this can be achieved with fluorescent markers that are specifically incorporated into the respective biomolecules. In the past, this has been achieved by incorporating a marker in the biomolecule by completely rebuilding it from the beginning, necessitating a large number of steps. Unfortunately, this approach not only takes a lot of time and resources, but also produces unwanted waste products. Researchers at the Universities of Göttingen and Edinburgh have now been able to show that a non-toxic complex of the common metal manganese makes it possible to conveniently label a class of special biomolecules known as peptides right at the last minute of their synthesis. This means the mechanism of action of these labelled peptides can be investigated efficiently.
A new technique using a complex of manganese, allows efficient labelling of, for instance, immune CD8+ T-cells with a flourescent lipopeptide
Nikolaos Kaplaneris, University of Göttingen
The research group developed the selective labelling of peptides and natural biological products at a late point in the series of steps necessary for synthesis by activating carbon-hydrogen bonds in tryptophan residues. This experimentally simple strategy makes it possible to efficiently access novel fluorescent peptides that are highly sensitive to their biological environment. This enabled the team to create a highly sensitive “rotor” with the ability to show changes in the composition of membranes of immune cells. Its fluorescence is dependent on the viscosity of the cell membrane. The researchers observed radiant fluorescence in the presence of cholesterol in the cell membrane. In this way, the rotor can be used to screen certain molecules in cells that are important for the adaptive immune system to fight infections and cancer.
"The project demonstrates the power of combining chemical, biological and medical research, which allows the direct observation of cell-specific events," says project leader Professor Lutz Ackermann from Göttingen University. "Furthermore, the successful collaboration ensures our discoveries to have an immediate impact not only in the field of chemistry, but also in the biomedical sciences. Sharing ideas and expertise between the teams enabled a joint approach to real-life problems."
Original publication
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Method aims to predict allergenic potency of chemicals
QIAGEN partners with sequencing provider
Making cars and airplanes cheaper, safer and more efficient - DFG funds 2 major instruments to test components made of fiber-reinforced composites
Enterome and Nestlé Health Science launch new diagnostics company
New wheat diversity discovery could provide an urgently-needed solution to global food security - Newly-discovered diversity in the wheat genome could offer vital new opportunities to improve and ‘climate-proof’ one of the world’s most important staple crops
Hidden properties of solids
Raman Microspectroscopy for Microbiology - Methodology can provide new insights into a variety of key topics in microbiology
Norwegian Team Completes Cod Genome
Biotage AB and McMaster University sign two year extension to Molecular Imaging Development Agreement
Malvern Panalytical agrees to acquire Micromeritics, to become world leaders in materials characterization
Aignostics Raises €14m Series A to Advance AI-powered Pathology - Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases